Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail.

Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, Guo W, Xia K, Liu G.

Oncol Lett. 2016 Dec;12(6):5007-5014. doi: 10.3892/ol.2016.5342.

2.

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.

Roggiani F, Mezzanzanica D, Rea K, Tomassetti A.

Int J Mol Sci. 2016 Aug 23;17(9). pii: E1387. doi: 10.3390/ijms17091387. Review.

3.

The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer.

Pranjol MZ, Gutowski N, Hannemann M, Whatmore J.

Biomolecules. 2015 Nov 20;5(4):3260-79. doi: 10.3390/biom5043260. Review.

4.

P-cadherin and the journey to cancer metastasis.

Vieira AF, Paredes J.

Mol Cancer. 2015 Oct 6;14:178. doi: 10.1186/s12943-015-0448-4. Review.

5.

Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.

Sakamoto K, Imai K, Higashi T, Taki K, Nakagawa S, Okabe H, Nitta H, Hayashi H, Chikamoto A, Ishiko T, Beppu T, Baba H.

Cancer Sci. 2015 Sep;106(9):1153-62. doi: 10.1111/cas.12732.

7.

Profiles of cancer stem cell subpopulations in cholangiocarcinomas.

Cardinale V, Renzi A, Carpino G, Torrice A, Bragazzi MC, Giuliante F, DeRose AM, Fraveto A, Onori P, Napoletano C, Franchitto A, Cantafora A, Grazi G, Caporaso N, D'Argenio G, Alpini G, Reid LM, Gaudio E, Alvaro D.

Am J Pathol. 2015 Jun;185(6):1724-39. doi: 10.1016/j.ajpath.2015.02.010.

8.
9.

Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.

Bryan RT.

Philos Trans R Soc Lond B Biol Sci. 2015 Feb 5;370(1661):20140042. doi: 10.1098/rstb.2014.0042. Review.

10.
11.

An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.

Pettee KM, Dvorak KM, Nestor-Kalinoski AL, Eisenmann KM.

PLoS One. 2014 Feb 28;9(2):e90371. doi: 10.1371/journal.pone.0090371.

12.

P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.

Usui A, Ko SY, Barengo N, Naora H.

Mol Cancer Res. 2014 Apr;12(4):504-13. doi: 10.1158/1541-7786.MCR-13-0489.

13.

Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells.

Jiao J, Huang L, Ye F, Shi M, Cheng X, Wang X, Hu D, Xie X, Lu W.

Onco Targets Ther. 2013 Jun 20;6:667-77. doi: 10.2147/OTT.S44177.

14.

Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors.

Niimi R, Matsumine A, Iino T, Nakazora S, Nakamura T, Uchida A, Sudo A.

BMC Cancer. 2013 Jun 26;13:309. doi: 10.1186/1471-2407-13-309.

15.
16.

Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.

Cheung LW, Yung S, Chan TM, Leung PC, Wong AS.

Mol Ther. 2013 Jan;21(1):78-90. doi: 10.1038/mt.2012.187.

17.

N-cadherin is differentially expressed in histological subtypes of papillary renal cell carcinoma.

Behnes CL, Hemmerlein B, Strauss A, Radzun HJ, Bremmer F.

Diagn Pathol. 2012 Aug 13;7:95. doi: 10.1186/1746-1596-7-95.

18.

Epithelial-mesenchymal transition in ovarian carcinoma.

Davidson B, Tropé CG, Reich R.

Front Oncol. 2012 Apr 10;2:33. doi: 10.3389/fonc.2012.00033.

19.

MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells.

Wu Z, Wu Z, Li J, Yang X, Wang Y, Yu Y, Ye J, Xu C, Qin W, Zhang Z.

Tumour Biol. 2012 Oct;33(5):1619-28. doi: 10.1007/s13277-012-0417-0.

20.

Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Serio RN.

Cancer Microenviron. 2012 Aug;5(2):173-83. doi: 10.1007/s12307-011-0092-5.

Supplemental Content

Support Center